Mike’s practice includes a broad range of debt finance and capital markets transactions, including acquisition and leveraged finance, private credit, structured finance (including royalty-based financings), debt capital markets (including high yield, convertible and investment grade bonds) and debt restructurings. With over two decades of experience, Mike is consistently recognized by The Legal 500 and Super Lawyers for his market leadership in both secured lending and debt capital markets. Mike is noted for his expertise on both the sponsor/borrower side and the bank side, and for his execution of high-profile transactions across a range of industries including life sciences, technology, healthcare, fintech and telecommunications.  

Download full bio 


  • Climate Tech Startup Arcadia Raises $125 Million in Funding 

  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • Eagle Pharmaceuticals – $150 Million in Funding 

  • Tempus Labs – $175 Million in Funding 

  • Clearside Biomedical – $65 Million Royalty Interest Purchase and Sale Agreement 

  • View all


  • Cornell Law School
    JD, John. M. Olin Foundation Scholar, 2002

  • Indiana University Bloomington
    BS, 1999

Admissions & Credentials


New York

District of Columbia